Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ICON plc

< Previous 1 2 3 Next >
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces CEO Transition
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Participate at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces Results of Annual General Meeting
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Second Quarter 2025 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
From ICON plc
Via Business Wire
Tickers ICLR
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Second Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON releases its ICON Cares 2024 Report
From ICON plc
Via Business Wire
Tickers ICLR
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports First Quarter 2025 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules First Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Fourth Quarter and Full Year 2024 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Issues Financial Guidance for Full Year 2025
From ICON plc
Via Business Wire
Tickers ICLR
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces Appointment of Chief Operating Officer
From ICON plc
Via Business Wire
Tickers ICLR
ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the Jefferies London Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Third Quarter 2024 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Third Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the Baird 2024 Global Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces Appointment of New Chief Financial Officer
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Second Quarter 2024 Results
From ICON plc
Via Business Wire
Tickers ICLR
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.